Drug Type Recombinant coagulation factor, Biosimilar |
Synonyms Human blood coagulation factor VIII, Moroctocog alfa biosimilar, Octofactor + [1] |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants), Blood coagulation pathway activation, Coagulation factor VIII replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date RU (01 Jan 2013), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemophilia A | RU | 01 Jan 2013 |